U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07115368) titled 'Study of GS-1219 in Participants With HIV-1' on Aug. 04.
Brief Summary: This study is part of a master study. The goal of master protocol (GSUS-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH).
Substudy GS-US-544-5905-04 is to learn more about study drug GS-1219, safety, pharmacokinetics (PK) (how GS-1219 is absorbed, modified, distributed, and removed from the body of the participants), and antiviral activity in Participants With HIV-1.
Study Start Date: Aug., 2025
Study Type: I...